Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California


Recent News and Articles on the Keywords: psoriasis + itch + unscratchable  Related to the article below (Last Update: 12/1/2008)

 News results: Standard Version | Text Version | Image Version  
Your search - psoriasis + itch + unscratchable - did not match any documents.
Suggestions:
Make sure all words are spelled correctly.
Try different keywords.
Try more general keywords.
Try fewer keywords.
Try Google Blog Search.
Also, you can browse today's headlines on the Google News homepage.
Source: Google News


 

Recent News and Articles on the Keywords: psoriasis + itch + unscratchable  Related to the article below (Last Update: 8/5/2008)

Manhattan Falls Short on Phase II Trial for Psoriasis
FDA news (subscription), VA -
Manhattan Pharmaceuticals? Phase IIa clinical study of topical PTH (1-34) for the treatment of mild-to-moderate plaque psoriasis failed to improve patients? ...OTC:MHAN
Study Reveals Novel LCD Solution Provides Significant Benefits ...
MarketWatch - Jul 31, 2008
Specifically, results of an interim analysis reveal the LCD solution is outperforming calcipotriol cream in achieving improvement of psoriasis symptoms ...
Manhattan Pharmaceuticals Announces Results of Phase 2a Study of ...
MarketWatch - Jul 31, 2008
... of treatment lesions or signs and symptoms of psoriasis (redness, scaling, plaque thickness, and itch) as compared to the vehicle (placebo) gel. ...OTC:MHAN
Barrier Therapeutics Introduces Dual-Component Xolegel CorePak(TM ...
MarketWatch - Jul 28, 2008
Now, patients with this chronic skin condition need only one prescription to get quick itch relief and to safely manage the overall condition long term. ...BTRX
Psoriasis: More Than Skin Deep
RedOrbit, TX - Jul 13, 2008
For decades, researchers have known that psoriasis-a chronic skin condition characterized by thick, red, scaly plaques that itch and bleed-can significantly ...

The Standard
Natural balm for itchy skin
The Standard, Hong Kong - Jul 7, 2008
Anyone with psoriasis knows the misery of an itch that never goes away. The worst part is that the skin condition is believed to be genetic, ...
Source: Google News

Itch -
G Yosipovitch, MW Greaves, M Schmelz - The Lancet, 2003 - Elsevier
... Psoriasis. Itch is a symptom reported in 80% of patients with psoriasis.
53 Findings of a study in psoriatic patients with widespread ...

Efalizumab for Patients With Moderate to Severe Plaque Psoriasis A Randomized Controlled Trial -
KB Gordon, KA Papp, TK Hamilton, PA Walicke, W … - JAMA, 2003 - Am Med Assoc
... that incorporates patients' assessments of itch, pain, feelings of embarrassment
and self-consciousness, problems with their psoriasis treatment, and ...

Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous … -
M Nakamura, M Toyoda, M Morohashi - British Journal of Dermatology, 2003 - Blackwell Synergy
... Objectives To clarify the mechanism and mediators involved in the pruritus of psoriasis
vulgaris, we compared itch-associated factors in lesional skin from ...

Scalp Psoriasis, Clinical Presentations and Therapeutic Management -
PCM van de Kerkhof, D de Hoop, J de Korte, MV … - Logo, 1998 - content.karger.com
... In scalp psoriasis, itch and scaling were the most frequent symptoms, whereas itch
and erythema were the most fre- quent symptoms on other localisations of ...

The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis -
G Yosipovitch, A Goon, J Wee, YH Chan, CL Goh - British Journal of Dermatology, 2000 - Blackwell Synergy
... itch. On the other hand, it would be of great interest to know whether diffuse
itch exacerbates psoriasis as a Koebner phenomenon. ...

Impact of efalizumab on psoriasis-specific patient-reported outcomes. Results from three randomized, …
A Menter, M Kosinski, BW Bresnahan, KA Papp, JE … - J Drugs Dermatol, 2004 - ncbi.nlm.nih.gov
... DRQL was measured using the Dermatology Life Quality Index (DLQI). Symptoms were
measured using the Psoriasis Symptom Assessment (PSA) and an Itch scale. ...

… Observed During 24 Weeks of Efalizumab Therapy in Patients With Moderate to Severe Plaque Psoriasis -
A Menter, K Gordon, W Carey, T Hamilton, S Glazer, … - Archives of Dermatology, 2005 - Am Med Assoc
... The validity and reliability of the DLQI in psoriasis as well as the itching scale
and PSA subscales used in this trial have been previously established. ...

Prevalence of symptoms experienced by patients with different clinical types of psoriasis -
F Sampogna, P Gisondi, CF Melchi, P Amerio, G … - British Journal of Dermatology, 2004 - Blackwell Synergy
... Even though in clinical practice it is known that in patients with psoriasis ?the
skin may itch, burn, sting, and bleed easily in affected areas?, 1 a ...

Validity and reliability of patient reported outcomes used in Psoriasis: results from two randomized … -
R Shikiar, BW Bresnahan, SP Stone, C Thompson, J … - Health and Quality of Life Outcomes, 2003 - hqlo.com
... DLQI), the Psoriasis Symptom Assessment (PSA) Scale, and two itch measures, a Visual
Analog Scale (VAS) and the National Psoriasis Foundation (NPF) itch measure ...

Depression Modulates Pruritus Perception: A Study of Pruritus in Psoriasis, Atopic Dermatitis and … -
MA GUPTA, AK GUPTA - Annals of the New York Academy of Sciences, 1999 - Blackwell Synergy
... patients hospitalized with psoriasis. British Journal of Dermatology 154:2,
325?331 ... Anjeli Krishnan & John Koo. (2005) Psyche, opioids, and itch: therapeutic ...

Source: Google Scholar
 
 

Psoriasis - The Unscratchable Itch

The word "psoriasis" is derived from the Greek word for "itch." but unlike some pesky prickle, psoriasis can’t be scratched away. More than seven million Americans suffer with psoriasis, a chronic skin disease characterized by an overproduction of skin cells that result in flaky and patchy raised areas on the skin’s surface.

Below, two experts in psoriasis offer a full introduction to this chronic disease. Let’s start with the basics. What is psoriasis?
MARK LEBWOHL, MD: Psoriasis is a disorder of the skin in which an abnormality of the immune system triggers the release of substances that cause the cells of the skin to multiply too quickly. Ordinarily, skin cells on the superficial area of the skin regenerate about every 28 days. In those with psoriasis, that same portion of the skin may be made over every two to four days, and that skin comes up as thick, scaly, red plaques.

Are there some parts of the body that are more susceptible to psoriasis than others?
KENNETH GORDON, MD: Typically traumatic areas are more susceptible, like elbows and knees, and the lower part of the back. But the important thing to remember is, psoriasis can happen anywhere on the body. Anywhere there’s skin you can have psoriasis.

 

Are there many different types?
MARK LEBWOHL, MD: Classically, there are four types. The most common type is plaque psoriasis, which is characterized by large, red, scaly patches that, as you’ve already heard, affect the elbows and knees, but can affect any part of the body. There are severe cases in which patients are covered, 80 to 100% of their body surface, with plaques. That accounts for the majority of patients with psoriasis.

Around 10% of patients have something called guttate psoriasis, which are smaller, red, scaly lesions-1 or 2 cm-that cover large areas of the body. Typically, these patients will develop a lot of little spots all over after strep throat. That’s the second most common type.

The two most dangerous types are called erythrodermic psoriasis and pustular psoriasis.

Erythrodermic psoriasis patients’ entire skin surface turns bright red and scaly, and they lose all of the protective functions of their skin. They literally can’t control body temperature. They lose nutrients and fluid through their skin and they’re susceptible to infection. The skin barrier against infection is lost, and that is a life-threatening form of psoriasis. Patients have actually died from that form of psoriasis.

 
Google
 
The other form, pustular psoriasis, occurs in two ways. One of them is generalized pustular psoriasis, in which, again, patients lose all of those protective functions of the skin, and this becomes a life-threatening instance where patients can die from their psoriasis. And there is a localized form which, while it is not life-threatening, is just as debilitating. It is a localized pustular psoriasis of the palms and soles. Patients simply can’t use their hands or feet. They can’t walk, they can’t handle anything with their hands, because it’s very painful.

How common are these more serious forms of psoriasis?
MARK LEBWOHL, MD: Fortunately they are rare. They’re most commonly triggered by systemic steroids, or withdrawal of systemic steroids.

If someone has a very chronic case of psoriasis, are other parts of the body affected by it?
MARK LEBWOHL, MD: The one particular part of the body that can routinely be affected in patients with psoriasis are the joints. It turns out that roughly 7%, or a little less than one out of ten patients who have psoriasis, will have significant psoriatic arthritis, meaning inflammation of the joints. There are several different forms of that, and it can range in severity from fairly mild to quite severe and debilitating.

Who gets psoriasis? How common is it?
MARK LEBWOHL, MD: It affects a little over 2.5% of the population, and it can affect anyone. Ordinarily, about a third of patients have a family history of the disease. Two-thirds of patients don’t know of someone else in the family had the disease. Nevertheless, it can affect anyone, and it can actually start at any age. There have been patients who were born with psoriasis. There are patients who develop psoriasis for the first time after the age of 100. An average age

Is it contagious?
KENNETH GORDON, MD: It is not contagious at all.

Why does psoriasis happen?
KENNETH GORDON, MD: A patient who is genetically predisposed to developing the disease will have some kind of immune challenge. That challenge will cause the immune cells, the lymphocytes, to respond and go to the skin and release cytokines, which induce the skin cells to change. The problem is, we don’t know exactly what causes those lymphocytes to behave in that manner, and that’s why we don’t fully understand the etiology. But we do know that the lymphocytes that cause those problems are necessary for the disease, and the elimination of their activity can help to treat the disease.

How significantly does this disease affect patients?
KENNETH GORDON, MD: The effects of psoriasis are very far-ranging in both patients’ health and the way they view themselves. Patients with psoriasis view their disease as something as disabling as diabetes or congestive heart failure. And it’s important to remember that these people have a very visible disease on their skin. They’re sometimes not allowed in a swimming pool because of the myth that psoriasis is contagious. Disease that affects only the palms or soles might be very debilitating because of pain on walking or holding a pencil. Patients will go a long way to try to get treatment because of the both mental and physical disabling properties of the disease.

So quite a severe psychological toll can be exacted, as well?
KENNETH GORDON, MD: There are surveys that show that the psychological toll of psoriasis is the equivalent of depression, which is about as severe as you can get.

What hope is there out there for patients who have it now?
MARK LEBWOHL, MD: I would say if you looked over the past 20 or 30 years at drugs that have been introduced for a variety of dermatologic conditions, an enormous proportion have been introduced for psoriasis. A lot of that is due to the patient advocacy groups, like the National Psoriasis Foundation, that have been pushing for new treatments. Also, there are a number of drugs on the horizon that will be approved for psoriasis that I think are both safer and as effective, or more effective, than many of the treatments we use today.

 

ALL THE NEWS : News1 ; News2 ; News3 ; News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 © 2002-2006

Keywords:

Contact Iconocast

Home Page